ARCHIVES

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Grants Payline Could Reach 175 Under Final Fiscal 1985 Awards Level Of Approximately 1,000

August 9, 1985

Researchers Call For New Approach To Peripheral Neuropathy Testing

February 24, 2012

The Cancer Letter Stands By Story

October 30, 1998

Some NCI Advisors Tell GAO Congress “Jumped The Gun” In Creating Cancer Control Program

October 26, 1979

Two activists Are Appointed To Complete NCAB

May 31, 1991

Thyroid Cancer Briefing Planned

July 8, 1977